Skip to main content

Advertisement

SpringerLink
Log in

Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

  • Therapeutic Aspects in Autoimmunity
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Headaches have been extensively reported in Antiphospholipid syndrome (APS)/Antiphospholipid antibodies (aPL)-positive patients. The aim of this study was to highlight the prevalence of headaches among APS/aPL-positive patients and discuss its association with laboratory, clinical and imaging findings. We searched the literature through Google Scholar and PubMed for publications on the epidemiology, pathogenesis, laboratory, imaging and clinical findings, and management of headaches in APS/aPL-positive patients. The following keywords were used: Antiphospholipid, Hughes syndrome, anticardiolipin, lupus anticoagulant, anti-β2 glycoprotein I, headache, migraine, tension, and cluster. All reports published between 1969 and 2015 were included. Migraine is the most commonly reported type of headache in APS/aPL-positive patients. Thrombotic and platelet dysfunction hypotheses have been studied to uncover the pathogenic role of aPL in the development of headaches. Several studies are reporting higher levels of aPL in primary and secondary APS migraineurs, but only few reached statistical significance. Migraine patients without clinical signs/symptoms of cerebral infarction rarely show positive imaging findings. Digital subtraction angiography shows promise in demonstrating small vascular lesions otherwise not detected on computed tomography, magnetic resonance imaging, or cerebral angiograms. Although it may be solitary and harmless in many cases, the deleterious effect of migraine on the quality of life of APS patients prompts rapid diagnosis and proper management. An anticoagulation trial is advisable in APS patients with migraine as many cases of severe, refractory migraine resolved with anticoagulation therapy. The profile of migraine headaches discussed in this study permits its candidacy for inclusion in future APS classification criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hughes G, Harris N, Gharavi A. The anticardiolipin syndrome. J Rheumatol. 1986;13(3):486–9.

    CAS  PubMed  Google Scholar 

  2. Merashli M, Noureldine MHA, Uthman I, Khamashta M. Antiphospholipid syndrome: an update. Eur J Clin Invest. 2015;45(6):653–62.

    Article  PubMed  Google Scholar 

  3. Khamashta M, Bertolaccini M, Hughes G. Antiphospholipid (Hughes) syndrome. Autoimmunity. 2004;37(4):309–12.

    Article  CAS  PubMed  Google Scholar 

  4. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33(12):2379.

    PubMed  Google Scholar 

  5. Espinosa G, Cervera R, Font J, Asherson R. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002;61(3):195–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tenedios F, Erkan D, Lockshin M. Cardiac involvement in the antiphospholipid syndrome. Lupus. 2005;14(9):691–6.

    Article  CAS  PubMed  Google Scholar 

  7. Kaushik S, Federle M, Schur P, Krishnan M, Silverman S, Ros P. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology. 2001;218(3):768–71.

    Article  CAS  PubMed  Google Scholar 

  8. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology. 2007;46(11):1641–7.

    Article  CAS  PubMed  Google Scholar 

  9. D’Cruz D. Renal manifestations of the antiphospholipid syndrome. Lupus. 2005;14(1):45–8.

    Article  PubMed  Google Scholar 

  10. André M, Delèvaux I, Amoura Z, Corbi P, Courthaliac C, Aumaître O, et al. Ovarian vein thrombosis in the antiphospholipid syndrome. Arthritis Rheum. 2004;50(1):183–6.

    Article  PubMed  Google Scholar 

  11. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101(6):1333–44.

    PubMed  Google Scholar 

  12. Noureldine M, Khamashta M, Merashli M, Sabbouh T, Hughes G, Uthman I. Musculoskeletal manifestations of the antiphospholipid syndrome. Lupus. 2016;25(5):451–62.

    Article  CAS  Google Scholar 

  13. Muscal E, Brey R. Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus. 2010;19(4):406–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hughes G. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J. 1983;287(6399):1088.

    Article  CAS  Google Scholar 

  15. Rodrigues C, Carvalho J, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350–9.

    Article  PubMed  Google Scholar 

  16. Uthman I, Noureldine M, Berjawi A, Skaf M, Haydar A, Merashli M, et al. Hughes syndrome and Multiple sclerosis. Lupus. 2015;24(2):115–21.

    Article  CAS  PubMed  Google Scholar 

  17. Cervera R, Boffa M, Khamashta M, Hughes G. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889–93.

    Article  CAS  PubMed  Google Scholar 

  18. Shuaib A, Barklay L, Lee M, Suchowersky O. Migraine and anti-phospholipid antibodies. Headache. 1989;29(1):42–5.

    Article  CAS  PubMed  Google Scholar 

  19. Sanna G, Bertolaccini M, Cuadrado M, Laing H, Khamashta M, Mathieu A, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30(5):985–92.

    PubMed  Google Scholar 

  20. Asherson R, Mercey D, Phillips G, Sheehan N, Gharavi A, Harris E, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis. 1987;46(8):605–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Levine S, Deegan M, Futrell N, Welch K. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 1990;40(8):1181–9.

    Article  CAS  PubMed  Google Scholar 

  22. Hering R, Couturier E, Steiner T, Asherson R, Clifford RF. Anticardiolipin antibodies in migraine. Cephalalgia. 1991;11(1):19–21.

    Article  CAS  PubMed  Google Scholar 

  23. Gharavi A, Harris E, Asherson R, Hughes G. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987;46(1):1–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hering R, Couturier E, Asherson R, Steiner T. Anticardiolipin antibodies in cluster headache. Cephalalgia. 1991;11(2):101–2.

    Article  CAS  PubMed  Google Scholar 

  25. Iñiguez C, Pascual C, Pardo A, Martinez-Castrillo J, Alvarez-Cermeño J. Antiphospholipid antibodies in migraine. Headache. 1991;31(10):666–8.

    Article  PubMed  Google Scholar 

  26. Robbins L. Migraine and anticardiolipin antibodies-case reports of 13 patients, and the prevalence of antiphospholipid antibodies in migraineurs. Headache. 1991;31(8):537–9.

    Article  CAS  PubMed  Google Scholar 

  27. Markus H, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol. 1992;239(1):39–42.

    Article  CAS  PubMed  Google Scholar 

  28. Montalbán J, Cervera R, Font J, Ordi J, Vianna J, Haga H, et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 1992;42(3 Pt 1):681–2.

    Article  PubMed  Google Scholar 

  29. Hinse P, Schulz A, Haag F, Carvajal-Lizano M, Thie A. Anticardiolipin antibodies in oculocerebral ischaemia and migraine: prevalence and prognostic value. Cerebrovasc Dis. 1993;3(3):168–73.

    Article  Google Scholar 

  30. Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol. 1998;37(3):300–3.

    Article  CAS  PubMed  Google Scholar 

  31. Tietjen G, Day M, Norris L, Aurora S, Halvorsen A, Schultz L, et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 1998;50(5):1433–40.

    Article  CAS  PubMed  Google Scholar 

  32. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, Abarca-Costalago M, De Haro-Liger M, Rodriguez-Andreu J, et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus. 1999;8(2):151–7.

    Article  CAS  PubMed  Google Scholar 

  33. Verrotti A, Cieri F, Pelliccia P, Morgese G, Chiarelli F. Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res. 2000;30(2):109–11.

    Article  CAS  PubMed  Google Scholar 

  34. Intiso D, Crociani P, Fogli D, Grandone E, Cappucci G, Di Rienzo F, et al. Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. Neurol Sci. 2002;22(6):455–8.

    Article  CAS  PubMed  Google Scholar 

  35. Avcin T, Markelj G, Niksic V, Rener-Primec Z, Cucnik S, Zupancic M, et al. Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine. Cephalalgia. 2004;24(10):831–7.

    Article  CAS  PubMed  Google Scholar 

  36. Cavestro C, Micca G, Molinari F, Bazzan M, DI Pietrantonj C, Aloi R, et al. Migraineurs show a high prevalence of antiphospholipid antibodies. J Thromb Haemost. 2011;9(7):1350–4.

    Article  CAS  PubMed  Google Scholar 

  37. Stojanovich L, Kontic M, Smiljanic D, Djokovic A, Stamenkovic B, Marisavljevic D. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Clin Exp Rheumatol. 2013;31(5):756–60.

    PubMed  Google Scholar 

  38. Sanna G, Bertolaccini M, Cuadrado M, Khamashta M, Hughes G. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology. 2003;42(2):200–13.

    Article  CAS  PubMed  Google Scholar 

  39. Cuadrado M, Khamashta M, Hughes G. Sticky blood and headache. Lupus. 2001;10(6):392–3.

    Article  CAS  PubMed  Google Scholar 

  40. Hughes G. Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes’) syndrome. Postgrad Med J. 2003;79(928):81–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Olesen J, Steiner T. The international classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry. 2004;75(6):808–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Pilarska E, Lemka M, Bakowska A. Antiphospholipid antibodies in children with migraine. Neurol Neurochir Pol. 2006;40(4):291–6.

    CAS  PubMed  Google Scholar 

  43. Angelini L, Zibordi F, Zorzi G, Nardocci N, Caporali R, Ravelli A, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics. 1996;27(3):149–53. doi:10.1055/s-2007-973766.

    Article  CAS  PubMed  Google Scholar 

  44. Hogan M, Brunet D, Ford P, Lillicrap D. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci. 1988;15(4):420–5.

    CAS  PubMed  Google Scholar 

  45. Tietjen G. Migraine and antiphospholipid antibodies. Cephalalgia. 1992;12(2):69–74.

    Article  CAS  PubMed  Google Scholar 

  46. Tsakiris D, Kappos L, Reber G, Marbet G, Le Floch-Rohr J, Roux E, et al. Lack of association between antiphospholipid antibodies and migraine. Thromb Haemost. 1993;69(5):415–7.

    CAS  PubMed  Google Scholar 

  47. Hughes G. Antiphospholipid syndrome, migraine and stroke. Lupus. 2010;19(5):555–6.

    Article  PubMed  Google Scholar 

  48. Cuadrado M, Khamashta M, Hughes G. Migraine and stroke in young women. QJM. 2000;93(5):317–8.

    Article  CAS  PubMed  Google Scholar 

  49. Schürks M, Rist P, Bigal M, Buring J, Lipton R, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kruit M, van Buchem M, Launer L, Terwindt G, Ferrari M. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia. 2010;30(2):129–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Kurth T, Slomke M, Kase C, Cook N, Lee I, Gaziano J, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005;64(6):1020–6.

    Article  CAS  PubMed  Google Scholar 

  52. Fields R, Toubbeh H, Searles R, Bankhurst A. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol. 1989;16(5):623–5.

    CAS  PubMed  Google Scholar 

  53. Tzourio C, Kittner S, Bousser M, Alpérovitch A. Migraine and stroke in young women. Cephalalgia. 2000;20(3):190–9.

    Article  CAS  PubMed  Google Scholar 

  54. Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  55. Liang M, Corzillius M, Bae S, Lew R, Fortin P, Gordon C, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608.

    Article  Google Scholar 

  56. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsänoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Care Res. 2001;45(5):419–23.

    Article  CAS  Google Scholar 

  57. Brey R, Holliday S, Saklad A, Navarrete M, Hermosillo-Romo D, Stallworth C, et al. Neuropsychiatric syndromes in lupus Prevalence using standardized definitions. Neurology. 2002;58(8):1214–20.

    Article  CAS  PubMed  Google Scholar 

  58. Sibbitt WL, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.

    PubMed  Google Scholar 

  59. Hanly JG, McCurdy G, Fougere L, Douglas J-A, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31(11):2156–62.

    PubMed  Google Scholar 

  60. Love P, Santoro S. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112(9):682–98.

    Article  CAS  PubMed  Google Scholar 

  61. Isenberg D, Meyrick-Thomas D, Snaith M, McKeran R, Royston J. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis. 1982;41(1):30–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Anzola G, Dalla Volta G, Balestrieri G. Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings. Arch Neurol. 1988;45(10):1061–2.

    Article  CAS  PubMed  Google Scholar 

  63. Asherson R, Khamashta M, Gil A, Vazquez J, Chan O, Baguley E, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989;86(4):391–9.

    Article  CAS  PubMed  Google Scholar 

  64. Hess D. Stroke associated with antiphospholipid antibodies. Stroke. 1992;23(2 Suppl):I23–8.

    CAS  PubMed  Google Scholar 

  65. Czlonkowska A, Meurer M, Palasik W, Baranska-Gieruszczak M, Mendel T, Wierzchowska E. Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population? Acta Neurol Scand. 1992;86(3):304–7.

    Article  CAS  PubMed  Google Scholar 

  66. Vrethem M, Ernerudh J, Lindström F, Olsson J. Cerebral ischemia associated with anticardiolipin antibodies. Acta Neurol Scand. 1992;85(6):412–7.

    Article  CAS  PubMed  Google Scholar 

  67. Weinberger J. Stroke and migraine. Curr Cardiol Rep. 2008;1(9):13–9.

    Google Scholar 

  68. Bousser M-G, Welch KMA. Relation between migraine and stroke. Lancet Neurol. 2005;4(9):533–42.

    Article  PubMed  Google Scholar 

  69. Boey M, Colaco C, Gharavi A, Elkon K, Loizou S, Hughes G. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J. 1983;287(6398):1021–3.

    Article  CAS  Google Scholar 

  70. Glueck H, Kant K, Weiss M, Pollak V, Miller M, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med. 1985;145(8):1389–95.

    Article  CAS  PubMed  Google Scholar 

  71. Gastineau D, Kazmier F, Nichols W, Bowie E. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985;19(3):265–75.

    Article  CAS  PubMed  Google Scholar 

  72. Alving B, Baldwin P, Richards R, Jackson B. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Thromb Haemost. 1985;54(3):709–12.

    CAS  PubMed  Google Scholar 

  73. Harris E, Chan J, Asherson R, Aber V, Gharavi A, Hughes G. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med. 1986;146(11):2153–6.

    Article  CAS  PubMed  Google Scholar 

  74. Damasio H, Beck D. Migraine thrombocytopenia, and serotonin metabolism. Lancet. 1978;1(8058):240–2.

    Article  CAS  PubMed  Google Scholar 

  75. Lee SL, Miotti AB. Disorders of hemostatic function in patients with systemic lupus erythematosus. In: Seminars in arthritis and rheumatism, vol 3. Elsevier; 1975.

  76. Dvilansky A, Rishpon S, Nathan I, Zolotow Z, Korczyn A. Release of platelet 5-hydroxytryptamine by plasma taken from patients during and between migraine attacks. Pain. 1976;2(3):315–8.

    Article  CAS  PubMed  Google Scholar 

  77. Gladman D, Urowitz M, Tozman E, Glynn M. Haemostatic abnormalities in systemic lupus erythematosus. Q J Med. 1983;52(207):424–33.

    CAS  PubMed  Google Scholar 

  78. Karpatkin S, Siskind G. In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood. 1969;33(6):795–812.

    CAS  PubMed  Google Scholar 

  79. Harris E, Gharavi A, Hegde U, Derue G, Morgan S, Englert H, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol. 1985;59(2):231–4.

    Article  CAS  PubMed  Google Scholar 

  80. McCarren TJ, Hitzemann R, Smith R, Glueck C. Membranes and migraine. Cephalalgia. 1985;5(3 suppl):548–9.

    Google Scholar 

  81. Oxman T, Hitzemann R, Smith R. Platelet membrane lipid composition and the frequency of migraine. Headache. 1982;22(6):261–7.

    Article  CAS  PubMed  Google Scholar 

  82. Shattil S, Cooper R. Role of membrane lipid composition, organization, and fluidity in human platelet function. Prog Hemost Thromb. 1978;4:59–86.

    CAS  PubMed  Google Scholar 

  83. Hughes G. Connective tissue disease and the skin. Clin Exp Dermatol. 1984;9(6):535–44.

    Article  CAS  PubMed  Google Scholar 

  84. Briley D, Coull B, Goodnight S Jr. Neurological disease associated with antiphospholipid antibodies. Ann Neurol. 1989;25(3):221–7.

    Article  CAS  PubMed  Google Scholar 

  85. Gallo P, Sivieri S, Ferrarini A, Giometto B, Ruffatti A, Ritter E, et al. Cerebrovascular and neurological disorders associated with antiphospholipid antibodies in CSF and serum. J Neurol Sci. 1994;122(1):97–101.

    Article  CAS  PubMed  Google Scholar 

  86. Levine SR, Joseph R, D’Andrea G, Welch K. Migraine and the lupus anticoagulant case reports and review of the literature. Cephalalgia. 1987;7(2):93–9.

    Article  CAS  PubMed  Google Scholar 

  87. Williams F, Cherkas L, Bertolaccini M, Murru V, Surdulescu G, Hughes G, et al. Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia. 2008;28(10):1048–52.

    Article  CAS  PubMed  Google Scholar 

  88. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun. 2000;15(2):145–51.

    Article  CAS  PubMed  Google Scholar 

  89. Cervera R, Khamashta M, Font J, Sebastiani G, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine. 1993;72(2):113–24.

    Article  CAS  PubMed  Google Scholar 

  90. Sanna G, D’Cruz D, Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am. 2006;32(3):465–90.

    Article  PubMed  Google Scholar 

  91. Ciubotaru C, Esfahani F, Benedict R, Wild L, Baer A. Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome. J Clin Rheumatol. 2002;8(6):332–9.

    Article  PubMed  Google Scholar 

  92. Gutrecht J, Kattwinkel N, Stillman M. Retinal migraine, chorea, and retinal artery thrombosis in a patient with primary antiphospholipid antibody syndrome. J Neurol. 1991;238(1):55–6.

    Article  CAS  PubMed  Google Scholar 

  93. Silvestrini M, Matteis M, Troisi E, Cupini L, Zaccari G, Bernardi G. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol. 1994;34(6):316–9.

    Article  CAS  PubMed  Google Scholar 

  94. Hughes GR, Cuadrado M, Khamashta M, Sanna G. Headache and memory loss: rapid response to heparin inthe antiphospholipid syndrome. Lupus. 2001;10(11):778.

    Article  CAS  PubMed  Google Scholar 

  95. Silvestrini M, Cupini L, Matteis M, De Simone R, Bernardi G. Migraine in patients with stroke and antiphospholipid antibodies. Headache. 1993;33(8):421–6.

    Article  CAS  PubMed  Google Scholar 

  96. Kim JH, Choi C-G, Choi S-J, Lee HK, Suh DC. Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients. Korean J Radiol. 2000;1(1):5–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Zhu D, Fu J, Zhang Y, Li S, Zhang G, Guan Y, et al. Neurological antiphospholipid syndrome: clinical, neuroimaging, and pathological characteristics. J Neurol Sci. 2014;346(1–2):138–44.

    Article  CAS  PubMed  Google Scholar 

  98. Erkan D, Aguiar C, Andrade D, Cohen H, Cuadrado M, Danowski A, et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014;13(6):685–96.

    Article  CAS  PubMed  Google Scholar 

  99. Hughes GR. Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons. Autoimmun Rev. 2008;7(3):262–6.

    Article  PubMed  Google Scholar 

  100. Thonnard-Neumann E. Migraine therapy with heparin: pathophysiologic basis. Headache. 1977;16(6):284–92.

    Article  CAS  PubMed  Google Scholar 

  101. Morales-Asín F, Iñiguez C, Cornudella R, Mauri J, Espada F, Mostacero E. Patients with acenocoumarol treatment and migraine. Headache. 2000;40(1):45–7.

    Article  PubMed  Google Scholar 

  102. Rahimtoola H, Egberts A, Buurma H, Tijssen C, Leufkens H. Reduction in the intensity of abortive migraine drug use during coumarin therapy. Headache. 2001;41(8):768–73.

    Article  CAS  PubMed  Google Scholar 

  103. der Heijden Wammes-van. E, Tijssen C, van’t Hoff A, Egberts A. A thromboembolic predisposition and the effect of anticoagulants on migraine. Headache. 2004;44(5):399–402.

    Article  Google Scholar 

  104. Asherson R, Giampaulo D, Singh S, Sulman L. Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome. J Clin Rheumatol. 2007;13(3):173–4.

    Article  CAS  PubMed  Google Scholar 

  105. King E, Odette W. Complex migraine with subtherapeutic INR in antiphospholipid syndrome. Am J Med. 2012;125(11):9–10.

    Article  Google Scholar 

  106. Mayer M, Cerovec M, Rados M, Cikes N. Antiphospholipid syndrome and central nervous system. Clin Neurol Neurosurg. 2010;112(7):602–8.

    Article  PubMed  Google Scholar 

  107. D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, et al. Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurolog Sci. 2009;30:S121–4.

    Article  Google Scholar 

Download references

Funding

No funds were allocated for the preparation of this work.

Author information

Authors and Affiliations

  1. Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University Medical Center, Beirut, Lebanon

    Mohammad Hassan A. Noureldine, Ali A. Haydar & Ahmad Berjawi

  2. Department of Neurology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

    Rody Elnawar

  3. Department of Neurosurgery, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

    Ahmad Sweid

  4. Lupus Research Unit, The Rayne Institute, Division of Women’s Health, St Thomas Hospital, London, UK

    Munther A. Khamashta

  5. Department of Rheumatology, Dubai Hospital, Dubai, UAE

    Munther A. Khamashta

  6. Head of the London Lupus Center, London Bridge Hospital, London, UK

    Graham R. V. Hughes

  7. Division of Rheumatology, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Riad El-Solh, Beirut, 1107 2020, Lebanon

    Imad Uthman

Authors
  1. Mohammad Hassan A. Noureldine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali A. Haydar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmad Berjawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rody Elnawar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmad Sweid
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Munther A. Khamashta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Graham R. V. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Imad Uthman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Imad Uthman.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest related to the publication of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noureldine, M.H.A., Haydar, A.A., Berjawi, A. et al. Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?. Immunol Res 65, 230–241 (2017). https://doi.org/10.1007/s12026-016-8831-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-016-8831-9

Keywords

Search

Navigation